Rapamycin extends murine lifespan but has limited effects on aging
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Aging is a major risk factor for a large number of disorders and functional impairments. Therapeutic targeting of the aging process may therefore represent an innovative strategy in the quest for novel and broadly effective treatments against age-related diseases. The recent report of lifespan extension in mice treated with the FDA-approved mTOR inhibitor rapamycin represented the first demonstration of pharmacological extension of maximal lifespan in mammals. Longevity effects of rapamycin may, however, be due to rapamycin's effects on specific life-limiting pathologies, such as cancers, and it remains unclear if this compound actually slows the rate of aging in mammals. Here, we present results from a comprehensive, large-scale assessment of a wide range of structural and functional aging phenotypes, which we performed to determine whether rapamycin slows the rate of aging in male C57BL/6J mice. While rapamycin did extend lifespan, it ameliorated few studied aging phenotypes. A subset of aging traits appeared to be rescued by rapamycin. Rapamycin, however, had similar effects on many of these traits in young animals, indicating that these effects were not due to a modulation of aging, but rather related to aging-independent drug effects. Therefore, our data largely dissociate rapamycin's longevity effects from effects on aging itself.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“some SASP inhibitors can have agent-specific off-target effects, for example, rapamycin, which can cause nephrotoxicity, metabolic impairment and susceptibility to infections, at least at higher doses in mice109.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Rapamycin and its analogs (so-called ‘rapalogs’) suppress the SASP by inhibiting mTOR and appear to extend healthspan and lifespan in mice105,108,109.”
From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [109]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A study by Neff and colleagues found that rapamycin significantly reduced the proportion of 16 month old mice with cancer and/or precancerous lesions 87, and suggested that this indicated that the effects of rapamycin on lifespan was driven by its anti-cancer effects.”
From Targeting the biology of aging with mTOR inhibitors (2023) · cites this paper as [87]
In the citing paper
“Studies have provided evidence that rapamycin only prolongs lifespan through antitumor mechanisms, thereby inhibiting the main pathological changes in mice [190, 191].”
From Immunosenescence: a key player in cancer development (2020) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sahn, D. J., DeMaria, A., Kisslo, J., & Weyman, A. (1978) · Circulation · doi:10.1161/01.cir.58.6.1072 · Cited by 7,430
Rapamycin fed late in life extends lifespan in genetically heterogeneous mice
Harrison, D. E., Strong, R., Sharp, Z. D., Nelson, J. F., Astle, C. M., Flurkey, K., Nadon, N. L., Wilkinson, J. E., Frenkel, K., Carter, C. S., et al. (2009) · Nature · doi:10.1038/nature08221 · Cited by 3,766 · cited 10×
“Rapamycin treatment was essentially as previously described (9).”
InfluentialRegulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway
Kapahi, P., Zid, B. M., Harper, T., Koslover, D., Sapin, V., & Benzer, S. (2004) · Current Biology · doi:10.1016/j.cub.2004.03.059 · Cited by 1,293
Regulation of Yeast Replicative Life Span by TOR and Sch9 in Response to Nutrients
Kaeberlein, M., Powers, R. W., Steffen, K. K., Westman, E. A., Hu, D., Dang, N., Kerr, E. O., Kirkland, K. T., Fields, S., & Kennedy, B. K. (2005) · Science · doi:10.1126/science.1115535 · Cited by 1,293
Experience-Induced Neurogenesis in the Senescent Dentate Gyrus
Kempermann, G., Kuhn, H. G., & Gage, F. H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-09-03206.1998 · Cited by 1,150 · cited 1×
“There is a known strong age-dependent decline in adult hippocampal neurogenesis (21).”
Ribosomal Protein S6 Kinase 1 Signaling Regulates Mammalian Life Span
Selman, C., Tullet, J. M. A., Wieser, D., Irvine, E., Lingard, S. J., Choudhury, A. I., Claret, M., Al-Qassab, H., Carmignac, D., Ramadani, F., et al. (2009) · Science · doi:10.1126/science.1177221 · Cited by 1,120
Influence of TOR kinase on lifespan in C. elegans
Vellai, T., Takacs-Vellai, K., Zhang, Y., Kovacs, A. L., Orosz, L., & Müller, F. (2003) · Nature · doi:10.1038/426620a · Cited by 1,057
Extension of Chronological Life Span in Yeast by Decreased TOR Pathway Signaling
Powers, R. W., Kaeberlein, M., Caldwell, S. D., Kennedy, B. K., & Fields, S. (2006) · Genes & Development · doi:10.1101/gad.1381406 · Cited by 982
Rapamycin, But Not Resveratrol or Simvastatin, Extends Life Span of Genetically Heterogeneous Mice
Miller, R. A., Harrison, D. E., Astle, C. M., Baur, J. A., Boyd, A. R., de Cabo, R., Fernandez, E., Flurkey, K., Javors, M. A., Nelson, J. F., et al. (2011) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glq178 · Cited by 896
CellProfiler™: Free, Versatile Software for Automated Biological Image Analysis
Lamprecht, M. R., Sabatini, D. M., & Carpenter, A. E. (2007) · BioTechniques · doi:10.2144/000112257 · Cited by 895
Rogers, D. C., Fisher, E. M. C., Brown, S. D. M., Peters, J., Hunter, A. J., & Martin, J. E. (1997) · Mammalian Genome · doi:10.1007/s003359900551 · Cited by 795
Rapid Quantification of Adult and Developing Mouse Spatial Vision Using a Virtual Optomotor System
Prusky, G. T., Alam, N. M., Beekman, S., & Douglas, R. M. (2004) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.04-0541 · Cited by 772
mTOR Regulation and Therapeutic Rejuvenation of Aging Hematopoietic Stem Cells
Chen, C., Liu, Y., Liu, Y., & Zheng, P. (2009) · Science Signaling · doi:10.1126/scisignal.2000559 · Cited by 680
With TOR, Less Is More: A Key Role for the Conserved Nutrient-Sensing TOR Pathway in Aging
Kapahi, P., Chen, D., Rogers, A. N., Katewa, S. D., Li, P. W.-L., Thomas, E. L., & Kockel, L. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.05.001 · Cited by 660
An Emerging Role of mTOR in Lipid Biosynthesis
Laplante, M., & Sabatini, D. M. (2009) · Current Biology · doi:10.1016/j.cub.2009.09.058 · Cited by 620
Wilkinson, J. E., Burmeister, L., Brooks, S. V., Chan, C., Friedline, S., Harrison, D. E., Hejtmancik, J. F., Nadon, N., Strong, R., Wood, L. K., et al. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2012.00832.x · Cited by 619
Jia, K., Chen, D., & Riddle, D. L. (2004) · Development · doi:10.1242/dev.01255 · Cited by 615
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
Hidalgo, M., & Rowinsky, E. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204091 · Cited by 582
Houde, V. P., Brûlé, S., Festuccia, W. T., Blanchard, P.-G., Bellmann, K., Deshaies, Y., & Marette, A. (2010) · Diabetes · doi:10.2337/db09-1324 · Cited by 456 · cited 2×
“Although we were unable to detect any effect of rapamycin on fat mass in young mice (Supplemental Figure 10), previously documented direct effects of rapamycin on fat mass and adipogenesis (30, 31) caution against the conclusion that rapamycin’s effects were aging dependent.”
Rapamycin increases lifespan and inhibits spontaneous tumorigenesis in inbred female mice
Anisimov, V. N., Zabezhinski, M. A., Popovich, I. G., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Rosenfeld, S. V., & Blagosklonny, M. V. (2011) · Cell Cycle · doi:10.4161/cc.10.24.18486 · Cited by 299
Rapamycin Extends Maximal Lifespan in Cancer-Prone Mice
Anisimov, V. N., Zabezhinski, M. A., Popovich, I. G., Piskunova, T. S., Semenchenko, A. V., Tyndyk, M. L., Yurova, M. N., Antoch, M. P., & Blagosklonny, M. V. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091050 · Cited by 257
Noninvasive, In Vivo Assessment of Mouse Retinal Structure Using Optical Coherence Tomography
Fischer, M. D., Huber, G., Beck, S. C., Tanimoto, N., Muehlfriedel, R., Fahl, E., Grimm, C., Wenzel, A., Remé, C. E., van de Pavert, S. A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007507 · Cited by 251
Cardiac Aging in Mice and Humans: The Role of Mitochondrial Oxidative Stress
Dai, D.-F., & Rabinovitch, P. S. (2009) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2009.12.004 · Cited by 244
Halloran, J., Hussong, S. A., Burbank, R., Podlutskaya, N., Fischer, K. E., Sloane, L. B., Austad, S. N., Strong, R., Richardson, A., Hart, M. J., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.054 · Cited by 221
Stephen Fink, J., & Smith, G. P. (1980) · Brain Research · doi:10.1016/0006-8993(80)90695-2 · Cited by 210
Majumder, S., Caccamo, A., Medina, D. X., Benavides, A. D., Javors, M. A., Kraig, E., Strong, R., Richardson, A., & Oddo, S. (2012) · Aging Cell · doi:10.1111/j.1474-9726.2011.00791.x · Cited by 203
Blackwell, B.-N., Bucci, T. J., Hart, R. W., & Turturro, A. (1995) · Toxicologic Pathology · doi:10.1177/019262339502300503 · Cited by 196
Luteinizing hormone and testosterone secretion in young and old male mice
Coquelin, A., & Desjardins, C. (1982) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1982.243.3.e257 · Cited by 161
Chronic mTOR inhibition by rapamycin induces muscle insulin resistance despite weight loss in rats
Deblon, N., Bourgoin, L., Veyrat‐Durebex, C., Peyrou, M., Vinciguerra, M., Caillon, A., Maeder, C., Fournier, M., Montet, X., Rohner‐Jeanrenaud, F., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01716.x · Cited by 154
Fuchs, H., Gailus‐Durner, V., Adler, T., Aguilar‐Pimentel, J. A., Becker, L., Calzada‐Wack, J., da Silva‐Buttkus, P., Neff, F., Götz, A. A., Hans, W., et al. (2010) · Methods · doi:10.1016/j.ymeth.2010.08.006 · Cited by 151
Self-citationRapamycin extends lifespan and delays tumorigenesis in heterozygous p53+/− mice
Komarova, E. A., Antoch, M. P., Novototskaya, L. R., Chernova, O. B., Paszkiewicz, G., Leontieva, O. V., Blagosklonny, M. V., & Gudkov, A. V. (2012) · Aging · doi:10.18632/aging.100498 · Cited by 146
In pursuit of the longevity dividend
Olshansky, S. J., Perry, D. P., Miller, R. A., & Butler, R. N. (2006) · The Scientist (Philadelphia, Pa. Online)/The Scientist · Cited by 143
Pathology of Aging B6;129 Mice
Haines, D. C., Chattopadhyay, S., & Ward, J. M. (2001) · Toxicologic Pathology · doi:10.1080/019262301753385988 · Cited by 140
Echocardiographic assessment of global left ventricular function in mice
Stypmann, J., Engelen, M. A., Troatz, C., Rothenburger, M., Eckardt, L., & Tiemann, K. (2009) · Laboratory Animals · doi:10.1258/la.2007.06001e · Cited by 128
Self-citationConstitutive reductions in mTOR alter cell size, immune cell development, and antibody production
Zhang, S., Readinger, J. A., DuBois, W., Janka-Junttila, M., Robinson, R., Pruitt, M., Bliskovsky, V., Wu, J. Z., Sakakibara, K., Patel, J., et al. (2011) · Blood · doi:10.1182/blood-2010-05-287821 · Cited by 126
Yeager, N., Klein–Szanto, A. J., Kimura, S., & Cristofano, A. D. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3524 · Cited by 120
A rotarod suitable for quantitative measurements of motor incoordination in naive mice
Jones, B. J., & Roberts, D. J. (1968) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00537801 · Cited by 117
Tacrolimus and Sirolimus Cause Insulin Resistance in Normal Sprague Dawley Rats
Larsen, J. L., Bennett, R. G., Burkman, T., Ramirez, A. L., Yamamoto, S., Gulizia, J., Radio, S., & Hamel, F. G. (2006) · Transplantation · doi:10.1097/01.tp.0000229384.22217.15 · Cited by 81
Systemic First-Line Phenotyping
Gailus-Durner*, V., Fuchs*, H., Adler, T., Aguilar Pimentel, A., Becker, L., Bolle, I., Calzada-Wack, J., Dalke, C., Ehrhardt, N., Ferwagner, B., et al. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-59745-471-1_25 · Cited by 80
Self-citationRapamycin's Resurrection: A New Way to Target the Cancer Cell Cycle
Garber, K. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1517 · Cited by 72
Bulckaen, H., Prévost, G., Boulanger, É., Robitaille, G. A., Roquet, V., Gaxatte, C., Garçon, G., Corman, B., Gosset, P., Shirali, P., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00241.2007 · Cited by 64
Romero-Suarez, S., Shen, J., Brotto, L., Hall, T., Mo, C., Valdivia, H. H., Andresen, J., Wacker, M., Nosek, T. M., Qu, C.-K., et al. (2010) · Aging · doi:10.18632/aging.100190 · Cited by 61
Distribution of sirolimus in rat tissue
Napoli, K. L., Wang, M., Stepkowski, S. M., & Kahan, B. D. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00157-9 · Cited by 59
The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention
Kopelovich, L., Fay, J. R., Sigman, C. C., & Crowell, J. A. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0045 · Cited by 55
Rapamycin increases the yield and effector function of human γδ T cells stimulated in vitro
Li, H., & Pauza, C. D. (2010) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-010-0945-7 · Cited by 49
Investigation of Age-Related Cognitive Decline Using Mice as a Model System: Behavioral Correlates
Murphy, G. G., Rahnama, N. P., & Silva, A. J. (2006) · American Journal of Geriatric Psychiatry · doi:10.1097/01.jgp.0000209405.27548.7b · Cited by 48
Heinen, M., Hettich, M. M., Ryan, D. P., Schnell, S., Paesler, K., & Ehninger, D. (2012) · Neural Plasticity · doi:10.1155/2012/467251 · Cited by 46
Self-citationHematologic and clinical chemistry findings in control BALB/c and C57BL/6 mice.
Frith, C., Suber, R. L., & Umholtz, R. L. (1980) · PubMed · Cited by 43
Relationship of body temperature stability to mortality in aging mice
Reynolds, M. A., Ingram, D. K., & Talan, M. I. (1985) · Mechanisms of Ageing and Development · doi:10.1016/0047-6374(85)90003-x · Cited by 40
mTOR inhibition and erythropoiesis: microcytosis or anaemia?
Diekmann, F., Rovira, J., Díaz‐Ricart, M., Arellano, E. M., Vodenik, B., Jou, J. M., Corrons, J. V., Escolar, G., & Campistol, J. M. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr318 · Cited by 34
McCampbell, A. S., Harris, H. A., Crabtree, J. S., Winneker, R. C., Walker, C. L., & Broaddus, R. R. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0199 · Cited by 28
Kmieć, Z., Kotlarz, G., Smiechowska, B., & Myśliwski, A. (1998) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(97)00040-x · Cited by 21
Leuenberger, H.-G. W., & Kunstýř, I. (1976) · Journal of Gerontology · doi:10.1093/geronj/31.6.648 · Cited by 13
Haller, F., Prehn, C. P., & Adamski, J. (2010) · Protocol Exchange · doi:10.1038/nprot.2010.22 · Cited by 9
Self-citationExpression of tissue inhibitor of matrix metalloproteinase-1 in aging of transgenic mouse liver
Zhang, Y., Chen, X., Wu, D., Zhang, X., Yang, L., Shi, S., & Yin, Z. (2006) · Chinese Medical Journal · doi:10.1097/00029330-200603020-00013 · Cited by 9
Henson, S. M., & Aspinall, R. (2003) · Springer eBooks · doi:10.1007/978-94-017-0673-5_10 · Cited by 5
Expression of tissue inhibitor of matrix metalloproteinase-1 in aging of transgenic mouse liver
Zhang, Yumei, Chen, Xiang-mei, Wu, Di, Xueguang, LU, L., Yang, Shi, J.-R., et al. (2006) · 中华医学杂志:英文版 · Cited by 5
Harding, J. J. (2003) · Springer eBooks · doi:10.1007/978-94-017-0673-5_8 · Cited by 4
Research works printed but not linked: 4
- Olshansky, 2006, Scientist., 20, 28
- Frith, 1980, Lab Anim Sci., 30, 835
- Coquelin, 1982, Am J Physiol., 243, E257
- Sommer C, Straehle C, Köthe U, Hamprecht FA. 8th IEEE International Symposium on Biomedical Imaging. March 30–April 2, 2011; Chicago, Illinois, USA.
Cited by
Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375
Rapamycin: one drug, many effects
Li, J., Kim, S. G., & Blenis, J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.001 · Cited by 1,287
Spermidine in health and disease
Madeo, F., Eisenberg, T., Pietrocola, F., & Kroemer, G. (2018) · Science · doi:10.1126/science.aan2788 · Cited by 1,154
Cellular senescence and senolytics: the path to the clinic
Chaib, S., Tchkonia, T., & Kirkland, J. L. (2022) · Nature Medicine · doi:10.1038/s41591-022-01923-y · Cited by 1,134
Canonical Nlrp3 Inflammasome Links Systemic Low-Grade Inflammation to Functional Decline in Aging
Youm, Y.-H., Grant, R. W., McCabe, L. R., Albarado, D. C., Nguyen, K. Y., Ravussin, A., Pistell, P., Newman, S., Carter, R., Laque, A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.09.010 · Cited by 674
Metadata
- Authors
- Neff, F., Flores-Dominguez, D., Ryan, D. P., Horsch, M., Schröder, S., Adler, T., Afonso, L. C., Aguilar-Pimentel, J. A., Becker, L., Garrett, L., Hans, W., Hettich, M. M., Holtmeier, R., Hölter, S. M., Moreth, K., Prehn, C., Puk, O., Rácz, I., Rathkolb, B., Rozman, J., Naton, B., Ordemann, R., Adamski, J., Beckers, J., Bekeredjian, R., Busch, D. H., Ehninger, G., Graw, J., Höfler, H., Klingenspor, M., Klopstock, T., Ollert, M., Stypmann, J., Wolf, E., Wurst, W., Zimmer, A., Fuchs, H., Gailus-Durner, V., Hrabe de Angelis, M., & Ehninger, D.
- Affiliations
- Helmholtz Munich (DE)
- German Center for Neurodegenerative Diseases (DE)
- University Hospital Münster (DE)
- University of Bonn (DE)
- University Hospital Carl Gustav Carus (DE)
- Heidelberg University (DE)
- Technical University of Munich (DE)
- Ludwig-Maximilians-Universität München (DE)
- Max Planck Society (DE)
- Corresponding author
- Ehninger, Dan
- ORCID
- Ryan, Devon P.
- Adler, Thure
- Becker, Lore
- Garrett, Lillian
- Hans, Wolfgang
- Hettich, Moritz M.
- Hölter, Sabine M.
- Moreth, Kristin
- Prehn, Cornelia
- Puk, Oliver
- Rácz, Ildikó
- Rathkolb, Birgit
- Rozman, Jan
- Adamski, Jerzy
- Beckers, Johannes
- Bekeredjian, Raffi
- Busch, Dirk H.
- Ehninger, Gerhard
- Graw, Jochen
- Klingenspor, Martin
- Klopstock, Thomas
- Ollert, Markus
- Wolf, Eckhard
- Wurst, Wolfgang
- Zimmer, Andreas
- Fuchs, Helmut
- Ehninger, Dan
- Venue
- Journal of Clinical Investigation
- Published
- 2013-07-25
- Volume
- 123
- Issue
- 8
- Pages
- 3272-3291
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC3726163
- OpenAlex
- W2025133084
- Cited by
- 374
- References
- 58
- Citations by year
- 2026: 13 · 2025: 23 · 2024: 16 · 2023: 22 · 2022: 17 · 2021: 32 · 2020: 19 · 2019: 24 · 2018: 28 · 2017: 20 · 2016: 41 · 2015: 58 · 2014: 48 · 2013: 13
- FWCI
- 18.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion)
- DZNE Pub (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- rapamycin, lifespan extension, aging, mTOR inhibition, age-related phenotypes, longevity, C57BL/6J mice
- MeSH terms
- Aging, Animals, Cell Transformation, Neoplastic, Drug Evaluation, Preclinical, Granuloma, Immunoglobulins, Leukocyte Count, Liver, Liver Cirrhosis, Longevity, Male, Mice, Inbred C57BL, Oxygen Consumption, Phenotype, Platelet Count, Psychomotor Performance, T-Lymphocytes, Thyroid Gland, Survival Analysis, Maze Learning, Sirolimus, Mice, Muscle Strength, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.